Current Ex-Vivo Gene Therapy Technologies and Future Developments
Author:
Su Chen-Hsien,Erol Deniz
Publisher
Springer New York
Reference46 articles.
1. Hockemeyer D, Wang H, Kiani S, Lai CS, Gao Q, Cassady JP, Cost GJ, Zhang L, Santiago Y, Miller JC et al (2011) Genetic engineering of human pluripotent cells using TALE nucleases. Nat Biotechnol 29:731–734
2. Cavazzana-Calvo M, Thrasher A, Mavilio F (2004) The future of gene therapy. Nature 427:779–781
3. Townes TM (2008) Gene replacement therapy for sickle cell disease and other blood disorders. Am Soc Hematol Educ Program 1:193–196
4. Thomson JG, Ow DW (2006) Site-specific recombination systems for the genetic manipulation of eukaryotic genomes. Genesis 44:465–476
5. Schwartzberg PL, Goff SP, Robertson EJ (1989) Germ-line transmission of a c-abl mutation produced by targeted gene disruption in ES cells. Science 246:799–803